跳至主要内容
临床试验/IRCT20190804044429N12
IRCT20190804044429N12招募中3 期

The effects of synbiotic product on gut microbiota changes in patients with multiple sclerosis treated with dimethyl fumarate: A randomized, double-blind, placebo-control clinical trial

Mazandaran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Adults over 18 years of age with a recent diagnosis of MS or a first attack consistent with a high-risk primary clinical syndrome based on the McDonald 2017 criteria
  • Expanded disability status scale less than 4.5
  • Candidate for dimethyl fumarate

排除标准

  • Antibiotic use in the past month
  • Consumption of any product and supplement that contains probiotics during the last three months
  • Consumption of omega-3 and other antioxidants during the last month
  • Systemic glucocorticoid use during the last month
  • breastfeeding

研究者

相似试验

The effects of synbiotic product on gut microbiota... | 临床试验